TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
Author(s) -
Maria Luana Poeta,
Judith Manola,
Meredith A. Goldwasser,
Arlene A. Forastiere,
Nicole Benoit,
Joseph A. Califano,
John A. Ridge,
Jarrard Goodwin,
Daniel E. Kenady,
John R. Saunders,
William H. Westra,
David Sidransky,
Wayne M. Koch
Publication year - 2007
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa073770
Subject(s) - hazard ratio , medicine , mutation , confidence interval , head and neck cancer , head and neck squamous cell carcinoma , carcinoma , oncology , cancer , pathology , cancer research , gene , gastroenterology , genetics , biology
The abrogation of function of the tumor-suppressor protein p53 as a result of mutation of its gene, TP53, is one of the most common genetic alterations in cancer cells. We evaluated TP53 mutations and survival in patients with squamous-cell carcinoma of the head and neck.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom